1. Home
  2. TYRA vs AIOT Comparison

TYRA vs AIOT Comparison

Compare TYRA & AIOT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • TYRA
  • AIOT
  • Stock Information
  • Founded
  • TYRA 2018
  • AIOT 1993
  • Country
  • TYRA United States
  • AIOT United States
  • Employees
  • TYRA N/A
  • AIOT N/A
  • Industry
  • TYRA Biotechnology: Pharmaceutical Preparations
  • AIOT Telecommunications Equipment
  • Sector
  • TYRA Health Care
  • AIOT Telecommunications
  • Exchange
  • TYRA Nasdaq
  • AIOT Nasdaq
  • Market Cap
  • TYRA 681.7M
  • AIOT 594.8M
  • IPO Year
  • TYRA 2021
  • AIOT N/A
  • Fundamental
  • Price
  • TYRA $13.39
  • AIOT $5.30
  • Analyst Decision
  • TYRA Strong Buy
  • AIOT Strong Buy
  • Analyst Count
  • TYRA 7
  • AIOT 4
  • Target Price
  • TYRA $30.71
  • AIOT $10.50
  • AVG Volume (30 Days)
  • TYRA 185.2K
  • AIOT 1.5M
  • Earning Date
  • TYRA 11-06-2025
  • AIOT 11-11-2025
  • Dividend Yield
  • TYRA N/A
  • AIOT N/A
  • EPS Growth
  • TYRA N/A
  • AIOT N/A
  • EPS
  • TYRA N/A
  • AIOT N/A
  • Revenue
  • TYRA N/A
  • AIOT $391,206,000.00
  • Revenue This Year
  • TYRA N/A
  • AIOT $21.83
  • Revenue Next Year
  • TYRA N/A
  • AIOT $10.13
  • P/E Ratio
  • TYRA N/A
  • AIOT N/A
  • Revenue Growth
  • TYRA N/A
  • AIOT 119.82
  • 52 Week Low
  • TYRA $6.42
  • AIOT $3.70
  • 52 Week High
  • TYRA $29.60
  • AIOT $8.71
  • Technical
  • Relative Strength Index (RSI)
  • TYRA 59.58
  • AIOT 53.86
  • Support Level
  • TYRA $12.98
  • AIOT $5.09
  • Resistance Level
  • TYRA $13.92
  • AIOT $5.55
  • Average True Range (ATR)
  • TYRA 0.62
  • AIOT 0.24
  • MACD
  • TYRA 0.00
  • AIOT -0.03
  • Stochastic Oscillator
  • TYRA 55.66
  • AIOT 27.51

About TYRA Tyra Biosciences Inc.

Tyra Biosciences Inc is a clinical-stage biotechnology company focused on developing next-generation precision medicines that target large opportunities in Fibroblast Growth Factor Receptor (FGFR) biology. The company's in-house precision medicine platform, SNAP, enables rapid and precise drug design through iterative molecular SNAPshots that help to design and predict which product candidates may demonstrate the highest potency, selectivity, and tolerability in the clinic. The various drug candidates in the company's product pipeline are TYRA-300, TYRA-200, and TYRA-430: three clinical-stage, novel small molecules designed to overcome the toxicity and resistance liabilities of first-generation pan-FGFR inhibitors.

About AIOT PowerFleet Inc. Common Stock

PowerFleet Inc is engaged in Internet-of-Things (IoT) solutions providing valuable business intelligence for managing high-value enterprise assets that improve operational efficiencies. It provide critical information that powers unified operations throughout organizations. It is solving the challenge of inefficient data collection, real-time visibility, and analysis that leads to transformative business operations. Its SaaS cloud-based applications take data from IoT devices and ecosystem of third-party and partner applications to present actionable information for customer.

Share on Social Networks: